Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?: Commentary

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 5, 2008, Pages 252-253

  Bhatt, Deepak L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL;

ACUTE CORONARY SYNDROME; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; RISK BENEFIT ANALYSIS; RISK REDUCTION; SHORT SURVEY; ST SEGMENT ELEVATION; THROMBOSIS;

EID: 42649136593     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1164     Document Type: Short Survey

References (5)

1. Yusuf S et al. for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345: 494-502
2. Sabatine MS et al. for the CLARITY-TIMI 28 Investigators (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352:1179-1189
3. Bhatt DL (2006) Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction? Nat Clin Pract Cardiovasc Med 3:142-183
4. Bhatt DL and Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2:15-28
5. Bhatt DL (2007) Intensifying platelet inhibition - navigating between Scylla and Charybdis. N Engl J Med 357:2078-2081